Russian Pharma: Road map
21 May 2013
Shulyak SergeyGeneral DirectorDSM Group
Growth of the pharmaceutical market has stabilized
Source: DSM Group, audit of pharmaceutical market RF
Growth of the pharmaceutical market in dollars
Source: DSM Group, audit of pharmaceutical market RF
Turnover of drugs`market is positive in EURO
Source: DSM Group, audit of pharmaceutical market RF
Commercial segment in recent years growing much faster
Source: DSM Group, audit of pharmaceutical market RF
Retail segment is 74% Russian pharma market
Source: DSM Group, audit of pharmaceutical market RF
The largest contribution to the growth of pharma market - structural change in favor of expensive drugs
Source: DSM Group, audit of pharmaceutical market RF
Russian pharmaceutical market: a lot or a little?
Source: DSM Group, Rating: Expert 400 for 2012
Manufacturing of pharmaceutical products and medical devices in Russia
Source: GKS
Retail trade turnover
Source: GKS, DSM
Per capita consumption of medicines in Russia(pharma market)
Source: DSM Group, audit of pharmaceutical market RF
Per capita consumption of medicines are rising in direct proportion to income population
Source: DSM Group, GKS
Domestic products occupy 24% in terms of value, 60% in terms of volume
Source: DSM Group, audit of pharmaceutical market RF, 2012
Localized products occupy 32% in terms of value, 68% in terms of volume
Source: DSM Group, audit of pharmaceutical market RF, 2012
Forecast 2013
Source: DSM Group, audit of pharmaceutical market RF
Take coffee please!
www.dsm.ru